ATYR
aTyr Pharma, Inc.
0.305$
-9.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -4,742.4% | -146.4% | – | -403.3% | -9,411.0% | -29,412.3% | -32,624.2% | |
| – | – | – | – | – | – | – | 323.7% | 12.1% | – | 16.3% | 776.5% | 655.3% | 817.4% | |
| – | – | – | – | – | – | – | 422.5% | 14.0% | – | 20.7% | 736.5% | 1,271.9% | 2,630.0% | |
| – | – | – | – | – | – | – | 48.8% | -21.6% | – | -8.0% | 4,252.7% | -2,943.8% | 3,922.6% | |
| – | – | – | – | – | – | – | 18.7% | 1.9% | – | 15.8% | 1,194.1% | 27.7% | 40.5% | |
| – | – | – | – | – | – | – | 1,167.1% | 66.0% | – | 454.9% | -5,701.7% | 7,333.2% | -2,659.5% | |
| – | – | – | – | – | – | – | – | – | – | -0.6% | -111.6% | -211.5% | -283.7% | |
| – | – | – | – | – | – | – | 316.6% | 154.4% | – | 52.5% | 18,762.0% | 16,963.4% | 34,742.6% | |
| – | – | – | – | – | – | – | -3,258.8% | 74.1% | – | 104.1% | 3,649.3% | -5,115.7% | -541.1% | |
| – | – | – | – | – | – | – | -4,761.1% | -148.3% | – | -419.1% | -10,605.1% | -29,440.0% | -32,664.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.